SEC Tracker
Get the app
MDNC · XBRL financial data

Medinotec financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (MDNC's year ends in late February)

In thousands of dollarsNov 30, 2023Feb 29, 2024May 31, 2024Aug 31, 2024Nov 30, 2024Feb 28, 2025May 31, 2025Aug 31, 2025Nov 30, 2025Feb 28, 2026May 31, 2026Aug 31, 2026
Revenue2,0032,251*2,3271,8042,5653,525*2,1343,2362,5371,822*2,6513,201
Cost of revenue1,139year only(1,399)9711,524(7,367)*(1,209)1,2341,191968*1,3431,641
Gross profit864—9288331,041—9252,0021,346—1,3081,560
Research and development3(39)*(15)269(177)*(49)66826*822
General and administrative552(2,623)*(605)354379(2,401)*(570)725435587*594836
Total operating expenses606(2,959)*(659)398513(2,911)*(648)(1,474)(793)(1,119)*(1,127)(1,357)
Operating income (loss)258246*2694365271,959*277529553(264)*181203
Interest expense67(480)*(58)(47)(43)(28)*324078*79
Other income (expense)(6)10*114(4)(11)*1612(22)(16)*18(30)
Income tax expense (benefit)63(139)*127111171(1,283)*149194139(753)*—139
Net income (loss)(492)99*872853101,477*114347403(69)*22241
Earnings per share, basic USD per share(0.04)—0.010.020.03—0.010.030.03—0.020.00
Earnings per share, diluted USD per share——0.010.02——0.010.03———0.00
Weighted average shares, basic thousands of shares———————11,752———11,756
Weighted average shares, diluted thousands of shares———————11,752———11,756

Balance sheet

CSV

Fiscal quarters (MDNC's year ends in late February)

In thousands of dollarsNov 30, 2023Feb 29, 2024May 31, 2024Aug 31, 2024Nov 30, 2024Feb 28, 2025May 31, 2025Aug 31, 2025Nov 30, 2025Feb 28, 2026May 31, 2026Aug 31, 2026
Cash and cash equivalents2,6792,8092,5192,7582,6772,7701,9512,2482,8572,7572,5182,584
Accounts receivable765903597719922,6123,8872,5752,2602,3522,5142,619
Total current assets3,5944,3793,9354,9024,9206,4236,9555,9796,4736,4206,5736,437
Property and equipment, net342320316327378348345333326331345375
Right-of-use asset—625753453732261913591
Total assets3,9924,8044,3225,2965,3636,8097,4046,3726,8536,8136,9856,953
Accounts payable2———————————
Total current liabilities3368277721,5661,4751,5052,0911,5341,3521,1011,132955
Lease liability, non-current—40342821135————63
Total liabilities1,9172,6372,0722,7662,5372,5383,0351,5351,3531,1021,1331,019
Total stockholders' equity2,0752,1672,2502,5302,8264,2714,3694,8375,5005,7115,8525,934
Total liabilities and equity3,9924,8044,3225,2965,3636,8097,4046,3726,8536,8136,9856,953
Common shares outstanding (cover page) thousands of shares11,73411,73411,73411,73411,73411,73411,75611,75611,75611,75611,75611,756

Cash flows

CSV

Fiscal quarters (MDNC's year ends in late February)

In thousands of dollarsNov 30, 2023Feb 29, 2024May 31, 2024Aug 31, 2024Nov 30, 2024Feb 28, 2025May 31, 2025Aug 31, 2025Nov 30, 2025Feb 28, 2026May 31, 2026Aug 31, 2026
Net income (loss)(492)99*872853101,477*114347403(69)*22241
Depreciation and amortization17*34*2325*26*(1)*87*8*58*2122*
Net cash from operating activities382*(87)*246399*134*99*(759)1,224*563*(121)*(176)108*
Purchases of property and equipment—(3)*(6)(12)*(73)*1*———year only4047*
Net cash from investing activities—11*(6)(12)*(73)*1*———year only(40)(47)*
Net cash from financing activities(543)*274*(542)(192)*(110)*(51)*(38)(943)*(3)*0*——
Net change in cash(160)*130*(290)239*(82)*93*(819)297*609*(100)*(239)66*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Medinotec2,5843,201108*11.8M— 10-QAug 31, 2026
Lifeward9,4486,623(6,005)*2.8M1.6 quarters 10-QJun 30, 2026
Co-Diagnostics3,650166(7,153)*6.3M0.5 quarters 10-QJun 30, 2026
Mountain Crest Acquisition Corp. V18not reported(79)*2.9M0.2 quarters 10-QJun 30, 2026
Retractable Technologies2,6417,201(1,732)*29.9M1.5 quarters 10-QJun 30, 2026
CapsoVisionnot reported3,643(8,403)*50.0M— 10-QJun 30, 2026
Guided Therapeutics120(319)*96.5M0.0 quarters 10-QJun 30, 2026
OSR Health1,500316(2,421)*35.1M0.6 quarters 10-QJun 30, 2026
Sintx Technologies3,590452(2,767)*6.7M1.3 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.